Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis

[1]  J. Ioannidis,et al.  Establishment of genetic associations for complex diseases is independent of early study findings , 2004, European Journal of Human Genetics.

[2]  Alan E. Jackson,et al.  Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian population. , 2004, Diabetes.

[3]  J. Todd,et al.  Lack of Association of the Ala45Thr Polymorphism and Other Common Variants of the NeuroD Gene With Type 1 Diabetes , 2004 .

[4]  J. Todd,et al.  Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes. , 2004, Diabetes.

[5]  D. Moczulski,et al.  The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 1 diabetes mellitus in caucasians. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[6]  T. Klupa,et al.  The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 2 diabetes mellitus in a Polish population , 2003, Acta Diabetologica.

[7]  John P A Ioannidis,et al.  Genetic associations: false or true? , 2003, Trends in molecular medicine.

[8]  P. Dřevínek,et al.  NEUROD polymorphism Ala45Thr is associated with Type 1 diabetes mellitus in Czech children. , 2003, Diabetes research and clinical practice.

[9]  Thomas A Trikalinos,et al.  Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.

[10]  Junxia Zhang,et al.  [Association of polymorphism in neurogenic differentiation factor 1 gene with type 2 diabetes]. , 2002, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[11]  T. Egashira,et al.  Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4. , 2002, Metabolism: clinical and experimental.

[12]  E. Kawasaki,et al.  Current knowledge of Japanese type 1 diabetic syndrome , 2002, Diabetes/metabolism research and reviews.

[13]  S. Amemiya,et al.  The association of Ala45Thr polymorphism in NeuroD with child-onset Type 1a diabetes in Japanese. , 2002, Diabetes research and clinical practice.

[14]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[15]  T. Saruta,et al.  NeuroD/beta2 gene G-->A polymorphism may affect onset pattern of type 1 diabetes in Japanese. , 2001, Diabetes care.

[16]  J. Ioannidis,et al.  Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Eisenbarth,et al.  Genetic susceptibility factors of Type 1 diabetes in Asians , 2001, Diabetes/metabolism research and reviews.

[18]  Y. Kanazawa,et al.  Lack of association of the Ala45Thr variant in the BETA2/NEUROD1 with type 1 diabetes in Japanese. , 2000, Diabetes research and clinical practice.

[19]  T. Hansen,et al.  NeuroD / BETA 2 Gene Variability and Diabetes No Associations to Late-Onset Type 2 Diabetes but an A 45 Allele May Represent a Susceptibility Marker for Type 1 Diabetes Among Danes , 2000 .

[20]  C. Dina,et al.  Absence of replication in the French population of the association between beta 2/NEUROD-A45T polymorphism and type 1 diabetes. , 1999, Diabetes & metabolism.

[21]  Marc Montminy,et al.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus , 1999, Nature Genetics.

[22]  C. Dina,et al.  No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in Type II diabetes in France , 1999, Diabetologia.

[23]  S. Kondo,et al.  Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. , 1999, Diabetes.

[24]  J. Ioannidis.  Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. , 1998, JAMA.

[25]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[26]  M. Tsai,et al.  Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. , 1997, Genes & development.

[27]  M. Tsai,et al.  Analysis of Candidate Genes for Susceptibility to Type I Diabetes: A Case-Control and Family-Association Study of Genes on Chromosome 2q31–35 , 1997, Diabetes.

[28]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[29]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.